Seismic Therapeutic logo

Seismic Therapeutic

Emerging

Seismic Therapeutic raised $222M+ total ($121M Series B in 2023, $25M in 2025) using its IMPACT ML platform; dosed first patient in Phase 1 for S-4321 bifunctional antibody in autoimmune disease.

Best for: AI-Driven Immunology Drug DiscoveryEmerging, rapid growth
36
AI Score
Grade D
AI Visibility Score (Beta)
Life Sciences & BioTechAI-Driven Immunology Drug DiscoveryWebsiteUpdated October 2026

Company Overview

About Seismic Therapeutic

Seismic Therapeutic is a clinical-stage biotechnology company based in Boston, Massachusetts that applies machine learning to the discovery and development of novel immunotherapies for autoimmune diseases. Founded with a focus on precision immunology, Seismic built its IMPACT platform to model the complex biology of adaptive immunity — identifying which immune cell populations drive specific autoimmune conditions and designing biologics that precisely modulate those populations without broadly suppressing the immune system. This targeted approach aims to produce safer, more effective treatments for conditions like lupus, rheumatoid arthritis, and inflammatory bowel disease.

Business Model & Competitive Advantage

Seismic raised $121M in a Series B financing in December 2023 and an additional $25M in mid-2025, bringing total capital raised to over $222M. In 2025, the company dosed the first healthy subject in a Phase 1 clinical trial of S-4321, a novel bifunctional antibody designed to modulate dysregulated adaptive immunity across a range of autoimmune diseases. This milestone marks Seismic''s transition from a purely discovery-stage company to one with a clinical-stage asset. Sophie Jones, M.D., joined as Chief Financial Officer in June 2025, supporting the company''s ongoing capital strategy as it advances its pipeline.

Competitive Landscape 2025–2026

Seismic Therapeutic operates at the intersection of ML-driven drug discovery and immunology — a sector that has attracted significant investor and pharma partnership interest given the limited success of blunt immunosuppression therapies in the autoimmune space. The IMPACT platform''s ability to analyze immune cell biology and predict therapeutic interventions computationally represents a meaningful advance over traditional trial-and-error antibody screening, potentially compressing drug discovery timelines and improving first-in-class candidate quality.

Headquarters
Boston, Massachusetts that applies machine learning to the discovery
Curated content • Fact-checked and verified

Key Differentiators

Emerging Innovator

Seismic Therapeutic is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

36
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Synkrino Biotherapeutics logo

Synkrino Biotherapeutics

Life Sciences & BioTech
HealthtechAi PoweredB2bStartupNorth America

Synkrino Biotherapeutics is an Oakland, California-based biotechnology company applying artificial intelligence and multiomics analysis to drug discovery in immune-mediated and inflammatory diseases.

Emulate logo

Emulate

Life Sciences & BioTech
HealthtechB2bEnterpriseAi PoweredHardwarePlatformStartupScaleupGlobalNorth America

Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m

Neuralink logo

Neuralink

Life Sciences & BioTech
HealthtechHardwareAi PoweredB2b2cStartupDecacornNorth AmericaTechnologyPlatformEnterprise

Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa

Saluda Medical logo

Saluda Medical

Life Sciences & BioTech
HealthtechHardwareB2bGlobalStartupAi Powered

Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper

Tempus logo

Tempus

Life Sciences & BioTech
HealthtechB2bAi PoweredAnalyticsPlatformPublicSaasTechnologyNorth America

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o

Karius logo

Karius

Life Sciences & BioTech
HealthtechAi PoweredB2bEnterpriseNorth AmericaTechnologyAnalytics

Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens

For Seismic Therapeutic

Claim This Profile

Are you from Seismic Therapeutic? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Seismic Therapeutic Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Seismic Therapeutic vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →